|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
BLUE | Smith-Farrell Joanne | COO, Oncology | Jan 05 | Sale | 44.95 | 42 | 1,888 | 21,896 | Jan 08 05:56 PM |
BLUE | Smith-Farrell Joanne | COO, Oncology | Jan 06 | Sale | 45.05 | 1,287 | 57,984 | 20,609 | Jan 08 05:56 PM |
BLUE | Smith-Farrell Joanne | COO, Oncology | Dec 02 | Sale | 46.20 | 38 | 1,756 | 21,938 | Dec 04 04:48 PM |
BLUE | Smith-Farrell Joanne | COO, Oncology | Nov 02 | Sale | 52.97 | 37 | 1,960 | 21,976 | Nov 04 04:05 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Oct 02 | Sale | 52.77 | 38 | 2,005 | 22,013 | Oct 06 04:06 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Sep 03 | Sale | 58.60 | 36 | 2,110 | 22,051 | Sep 08 04:08 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Aug 25 | Sale | 58.95 | 225 | 13,264 | 22,087 | Aug 27 05:11 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Aug 03 | Sale | 60.48 | 37 | 2,238 | 22,312 | Aug 05 04:05 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Jul 02 | Sale | 61.57 | 38 | 2,340 | 22,349 | Jul 07 05:17 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Jun 04 | Sale | 65.23 | 170 | 11,089 | 22,387 | Jun 08 04:24 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Jun 02 | Sale | 64.03 | 37 | 2,369 | 22,557 | Jun 04 05:44 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | May 04 | Sale | 50.17 | 232 | 11,639 | 22,594 | May 05 04:05 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Apr 06 | Sale | 43.73 | 583 | 25,495 | 21,393 | Apr 08 04:12 PM |
BLUE | Smith-Farrell Joanne | Chief Business Officer | Jan 07 | Sale | 89.97 | 408 | 36,708 | 11,976 | Jan 09 05:33 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite